| Issue Date | Title | Author(s) |
| 2023-07 | Intraperitoneal Administration of Empagliflozin Reduces Myocardial Infarct Size in Mice | Wu, J; Gao, L; Villanueva, J; Doyle, A; Joshi, Y; Kesteven, S; Lismaa, S; Feneley, M; Graham, B; Macdonald, P |
| 2023-09 | Metabolic Sequelae of Everolimus Treatment After Cardiac Transplant: A Hypothesis-Generating Study. | Raven, LM; Muir, CA; Pouliopoulos, J; Hayward, CS; Macdonald, PS; Greenfield, JR; Jabbour, A |
| 2016-04-28 | Hypertension: What are the self-care and health-care-seeking behaviours in women over time? | Sibbritt, D; Davidson, P; Peng, WB; Adams, J; Hickman, L |
| 2023-06 | Heart Transplantation Using Donation After Circulatory Death (DCD) Donors: St Vincent’s Hospital Experience Update | Soto, C; Joshi, Y; Scheuer, S; Chew, H; Iyer, A; Dinale, A; Cropper, J; Roshan, A; Sgammotta, E; Jansz, P; Macdonald, P |
| 2023-11-07 | Abstract 18365: Elevated Biomarkers of Subclinical Myocardial Injury and Inflammation Among Community-Dwelling Adults With Covid-19 | Ogungbe, OV; deCardi Hladek, M; Sokoll, L; Mohr, P; Dennison Himmelfarb, CR; Davidson, P; Post, WS; Farley, J; Commodore-Mensah, Y |
| 2023-07 | New Drug Targets and Preclinical Modelling Recommendations for Treating Acute Myocardial Infarction. | Cao, Y; Redd, MA; Fang, C; Mizikovsky, D; Li, X; Macdonald, PS; King, GF; Palpant, NJ |
| 2024-05-30 | Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |
| 2024-05-09 | Randomized comparison of the effects of tailored text messaging versus pillbox organizers on medication adherence of heart failure patients. | FarzanehRad, A; Allahbakhshian, A; Gholizadeh, L; Khalili, AF; Hasankhani, H |
| 2024-05-01 | Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |
| 2024-01-23 | Statistical analysis plan for the Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke randomised controlled clinical trial. | Kilkenny, MF; Olaiya, MT; Cameron, J; Lannin, NA; Andrew, NE; Thrift, AG; Hackett, M; Kneebone, I; Drummond, A; Thijs, V; Brancatisano, O; Kim, J; Reyneke, M; Hancock, S; Allan, L; Ellery, F; Cloud, G; Grimley, RS; Middleton, S; Cadilhac, DA; Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS) investigators, |
